[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU9128998A - Composition and method for the treatment of benign prostatic hyperplasia and prostatitis - Google Patents

Composition and method for the treatment of benign prostatic hyperplasia and prostatitis

Info

Publication number
AU9128998A
AU9128998A AU91289/98A AU9128998A AU9128998A AU 9128998 A AU9128998 A AU 9128998A AU 91289/98 A AU91289/98 A AU 91289/98A AU 9128998 A AU9128998 A AU 9128998A AU 9128998 A AU9128998 A AU 9128998A
Authority
AU
Australia
Prior art keywords
prostatitis
treatment
composition
benign prostatic
prostatic hyperplasia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU91289/98A
Inventor
Andrew E. Myers
Mark R. Priddy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RICHARDSON LABS Inc
Original Assignee
RICHARDSON LABS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RICHARDSON LABS filed Critical RICHARDSON LABS
Publication of AU9128998A publication Critical patent/AU9128998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AU91289/98A 1997-09-04 1998-09-02 Composition and method for the treatment of benign prostatic hyperplasia and prostatitis Abandoned AU9128998A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92366997A 1997-09-04 1997-09-04
US08923669 1997-09-04
PCT/US1998/018199 WO1999011279A1 (en) 1997-09-04 1998-09-02 Composition and method for the treatment of benign prostatic hyperplasia and prostatitis

Publications (1)

Publication Number Publication Date
AU9128998A true AU9128998A (en) 1999-03-22

Family

ID=25449071

Family Applications (1)

Application Number Title Priority Date Filing Date
AU91289/98A Abandoned AU9128998A (en) 1997-09-04 1998-09-02 Composition and method for the treatment of benign prostatic hyperplasia and prostatitis

Country Status (2)

Country Link
AU (1) AU9128998A (en)
WO (1) WO1999011279A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004506683A (en) * 2000-08-24 2004-03-04 ザ　リージェンツ　オブ　ザ　ユニバーシティ　オブ　カリフォルニア α-Difluoromethylornithine (DFMO) suppresses polyamine levels in human prostate
FR2881649B1 (en) * 2005-02-10 2007-04-06 Du Sert Patrice Percie PROCESS FOR EXTRACTING FRESH POLLEN, LIPID EXTRACT OBTAINED AND APPLICATIONS THEREOF
US8221803B1 (en) 2007-06-25 2012-07-17 OncoNatural Solutions, Inc. Composition for prostate health
CN104055902B (en) * 2014-06-28 2016-08-17 张志红 One treats prostatitic Chinese medicine composition
EP4001282A4 (en) 2019-07-15 2023-07-19 Biolab Sanus Farmacéutica Ltda Stereoisomers of the compound 3-(benzo[d][1,3]dioxol-5-yl)-7-(1-hydroxypropan-2-yl)-1-(1h-indol-3-yl)-6,7-dihydro-3h-oxazol[3,4-a]pyrazine-5,8-dione and use thereof as an antitumor agent and phosphodiesterase enzyme inhibitor
CN114377107B (en) * 2022-01-14 2023-09-05 完美（广东）日用品有限公司 Application of sea buckthorn seed meal protein peptide in preparation of medicine for preventing and treating prostatic hyperplasia

Also Published As

Publication number Publication date
WO1999011279A1 (en) 1999-03-11

Similar Documents

Publication Publication Date Title
AU6393896A (en) Method for treating benign prostatic hyperplasia with thermal therapy
EP1014995A4 (en) Compositions and methods for preventing restenosis following revascularization procedures
AU1316000A (en) Compositions and methods for treating benign prostatic hyperplasia using tocotrienols
AU2212299A (en) Compositions and methods for the treatment of tumor
AU6578998A (en) Method of treatment of migraine
AU9214398A (en) Compositions and methods for treating water
IL189132A0 (en) Pharmaceutical compositions for the treatment of prostate hypertrophy and prostate cancer
AU5173296A (en) Prostatic tissue expander
NO993396L (en) Quinoline and quinoline compounds useful in therapy, especially in the treatment of benign prostatic hyperplasia
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
AU2235395A (en) Biological markers of benign prostate hyperplasia
AU9016898A (en) Methods and compositions for treatment of restenosis
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
AU1657097A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
EP0855910A4 (en) Conjugates useful in the treatment of benign prostatic hyperplasia
AU1714697A (en) Method and composition for the treatment of osteoarthritis
ZA983968B (en) Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia.
HU9501286D0 (en) Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
AU9128998A (en) Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
ZA982819B (en) Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogn receptor modulators.
HK1030776A1 (en) Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
EP0633781A4 (en) Compositions and methods for treating benign prostatic hypertrophy.
AU5457694A (en) Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
AU6172896A (en) Melatonin agonists for treating benign prostatic hyperplasia
AUPO410796A0 (en) Method of treating benign prostatic hyperplasia

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase